Skip to main content

Table 2 Patient- and provider-level characteristics and rates of preoperative cardiac testing within 60 days prior of a low-risk surgical procedure in Alberta (N = 88,131 procedures) and Saskatchewan (N = 35,072 procedures) between June 2012 and March 2013

From: Measuring the frequency and variation of unnecessary care across Canada

   

Preoperative cardiac testing

Characteristic

Provincea

No. procedures

Rate per 100b

Odds Ratio (95% CI)c

Patient-level**

Age

 18–44 [ref]

Saskatchewan

5476

15.6

1.00

Alberta

16,736

19.0

1.00

 45–64

Saskatchewan

13,186

37.6

2.92 (2.63–3.23)*

Alberta

33,759

38.3

3.40 (3.18–3.62)*

 65+

Saskatchewan

16,410

46.8

4.56 (4.11–5.06)*

Alberta

37,636

42.7

4.89 (4.56–5.24)*

Sex

 Male [ref]

Saskatchewan

16,134

46.0

1.00

Alberta

40,945

46.5

1.00

 Female

Saskatchewan

18,938

54.0

0.95 (0.90–1.00)

Alberta

47,186

53.5

0.96 (0.93–1.00)

Comorbidityd

 No comorbidity [ref]

Saskatchewan

28,640

81.7

1.00

Alberta

63,526

72.1

1.00

 Comorbidity

Saskatchewan

6432

18.3

1.84 (1.73–1.96)*

Alberta

24,605

27.9

1.90 (1.82–1.97)*

Provider-level***

Anesthesiology consult

 No [ref]

Saskatchewan

34,077

97.2

1.00

Alberta

85,055

96.5

1.00

 Yes

Saskatchewan

995

2.8

6.16 (5.34–7.11)*

Alberta

3076

3.5

10.9 (9.99–11.9)*

Medical consult

 No [ref]

Saskatchewan

32,432

92.5

1.00

Alberta

82,150

93.2

1.00

 Yes

Saskatchewan

2640

7.5

6.30 (5.78–6.76)*

Alberta

5981

6.8

9.93 (9.36–10.5)*

  1. Notes: * P ≤ .05; **patient characteristics are adjusted for each other and procedure type; *** provider characteristics are adjusted for each other and procedure type; CI = confidence interval; [ref] = reference category
  2. a separate models were created for each province versus including province as a dichotomous variable
  3. b rate is the observed rate (# tests/n) at index procedure – (1 to 60 d) for each patient in denominator
  4. c odds ratio and 95% CI estimates based on multiple binary logistic regression models and adjusted for procedure type (endoscopic, ophthalmologic, or other)
  5. d indicator variable representing whether patient had history of any of the following comorbidities: coronary artery disease, congestive heart failure, atrial fibrillation, other cardiac arrhythmia, cardiac valvular disease, renal disease, previous cardiovascular disease, peripheral vascular disease, venous thromboembolism, COPD, diabetes, hypertension and/or asthma